MRVI insider buying and SEC filings, explained
Maravai Lifesciences Holdings, Inc. · CIK 1823239
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$1.9M
Insiders who bought
2
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$254K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 9–10, 2026 | Planned (10b5-1) | Kurt Oreshack (General Counsel) sold 50,000 shares between Jun 9 and Jun 10 at about $5.08 ($254K), marked as a 10b5-1 plan trade. Holdings down 13% to 335,767 shares. | SEC filing Filed Jun 10, 2026 |
| Dec 5–8, 2025 | Purchase (code P) | Gregory T. Lucier (Director) bought 100,000 shares between Dec 5, 2025 and Dec 8, 2025 at about $3.69 ($369K), reported as a purchase (code P). Holdings up 181% to 155,123 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 9, 2025 |
| Nov 13, 2025 | Purchase (code P) | Bernd Brust (CEO and Director) bought 216,212 shares indirectly (by trust) at about $3.25 ($703K), reported as a purchase (code P). Holdings by trust up 86% to 466,771 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 17, 2025 |
| Nov 11–12, 2025 | Purchase (code P) | Bernd Brust (CEO and Director) bought 250,559 shares indirectly (by trust) between Nov 11, 2025 and Nov 12, 2025 at about $3.23 ($809K), reported as a purchase (code P). New position of 250,559 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 13, 2025 |
25 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
2 insiders bought in 30 days
$1.9M in purchases since Nov 12, 2025 · Purchases traded Nov 12, 2025 to Dec 8, 2025 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Bernd Brust (CEO) | $809K | Nov 12, 2025 | SEC filing |
| Bernd Brust (CEO) | $703K | Nov 13, 2025 | SEC filing |
| Gregory T. Lucier (Director) | $369K | Dec 8, 2025 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow MRVI in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.